Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics (DMAC) Total Liabilities (2018 - 2019)

DiaMedica Therapeutics' Total Liabilities history spans 2 years, with the latest figure at $1.3 million for Q3 2019.

  • For Q3 2019, Total Liabilities rose 132.58% year-over-year to $1.3 million; the TTM value through Sep 2019 reached $1.3 million, up 132.58%, while the annual FY2018 figure was $1.3 million, N/A changed from the prior year.
  • Total Liabilities reached $1.3 million in Q3 2019 per DMAC's latest filing, up from $1.1 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $1.6 million in Q1 2019 to a low of -$48.0 million in Q2 2018.